Although not much has been determined about the predictive clinical significance and functional role of RAGE in BC, previous findings have proposed RAGE as a potential candidate biomarker for breast tumor development and progression, and as a promising therapeutic approach for the high invasive TNBC [14–16]. Here, AGER is linked to breast cancer.